Health Catalyst, Inc. (HCAT) vs OptimizeRx Corp. (OPRX)
- Health Catalyst, Inc. HCAT 1.47 −2.00%
- OptimizeRx Corp. OPRX 8.70 +0.35%
Health Catalyst, Inc. and OptimizeRx Corp. are both Health Information Services companies. OptimizeRx Corp. is the larger, with a market value of $163.3M against $112.9M — 1.4× the size. Health Catalyst, Inc. has negative trailing earnings, so its P/E is not meaningful; OptimizeRx Corp. trades at 35.8×. OptimizeRx Corp. grew revenue faster over the last twelve months: −5.82% against −13.9%. OptimizeRx Corp. has the higher net margin (4.66% vs −74.2%) and the higher return on invested capital (5.41% vs −167.9%). Across the 20 metrics below, OptimizeRx Corp. leads on 16 and Health Catalyst, Inc. on 4.
Valuation
Profitability
| Metric | HCAT | OPRX | Health Information Services median |
|---|---|---|---|
| Gross margin | 49.13% | 73.22% | 59.61% |
| Operating margin | (65.72%) | 11.04% | (10.54%) |
| Net margin | (74.24%) | 4.66% | (16.14%) |
| Free cash flow margin | 9.45% | 18.83% | 0.00% |
| Return on equity | (84.64%) | 3.68% | (3.15%) |
| Return on assets | (49.02%) | 2.76% | (5.62%) |
| Return on invested capital | (167.90%) | 5.41% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack